Biostar Pharmaceuticals, Inc.

BSPMOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$264

P/E Ratio—

52W High$0.0001

52W Low$0.0001

Avg Volume38

Open$0.00

Beta-163.62

Insider Trades Ownership Employees

Biostar Pharmaceuticals, Inc. (BSPM) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · BSPM · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Biostar Pharmaceuticals, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

Recent insider transactions

BSPM executive sell shares · BSPM board member insider trading · BSPM insider trading SEC filing

Showing 20 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Jun 16, 2011	Wang Ronghua Chairman, CEO · Director	Purchase	13,800	$1.10	$15K	9,166,973	Form 4
Jun 15, 2011	Wang Ronghua Chairman, CEO · Director	Purchase	14,350	$1.19	$17K	9,153,173	Form 4
Jun 14, 2011	Wang Ronghua Chairman, CEO · Director	Purchase	35,100	$1.23	$43K	9,138,823	Form 4
Jun 13, 2011	Wang Ronghua Chairman, CEO · Director	Purchase	22,050	$1.24	$27K	9,103,723	Form 4
Jun 10, 2011	Wang Ronghua Chairman, CEO · Director	Purchase	19,700	$1.21	$24K	9,081,673	Form 4
Jun 9, 2011	Wang Ronghua Chairman, CEO · Director	Purchase	12,000	$1.22	$15K	9,061,973	Form 4
Jun 8, 2011	Wang Ronghua Chairman, CEO · Director	Purchase	34,600	$1.26	$44K	9,049,973	Form 4
Jun 7, 2011	Wang Ronghua Chairman, CEO · Director	Purchase	8,600	$1.25	$11K	9,015,373	Form 4
Jun 6, 2011	Wang Ronghua Chairman, CEO · Director	Purchase	10,300	$1.24	$13K	9,006,773	Form 4
Jun 3, 2011	Wang Ronghua Chairman, CEO · Director	Purchase	6,900	$1.27	$9K	8,996,473	Form 4
Jun 2, 2011	Wang Ronghua Chairman, CEO · Director	Purchase	12,200	$1.29	$16K	8,989,573	Form 4
Jun 1, 2011	Wang Ronghua Chairman, CEO · Director	Purchase	100	$1.38	$138	8,977,373	Form 4
Jun 1, 2011	Wang Ronghua Chairman, CEO · Director	Purchase	200	$1.37	$274	8,977,273	Form 4
Jun 1, 2011	Wang Ronghua Chairman, CEO · Director	Purchase	1,300	$1.36	$2K	8,977,073	Form 4
Jun 1, 2011	Wang Ronghua Chairman, CEO · Director	Purchase	1,700	$1.35	$2K	8,975,773	Form 4
Jun 1, 2011	Wang Ronghua Chairman, CEO · Director	Purchase	1,700	$1.33	$2K	8,974,073	Form 4
Jun 1, 2011	Wang Ronghua Chairman, CEO · Director	Purchase	2,500	$1.32	$3K	8,972,373	Form 4
Jun 1, 2011	Wang Ronghua Chairman, CEO · Director	Purchase	1,811	$1.31	$2K	8,969,873	Form 4
Jun 1, 2011	Wang Ronghua Chairman, CEO · Director	Purchase	1.089	$1.30	$1	8,968,062	Form 4
May 19, 2011	Pan Zibing CFO	Purchase	30,000	$1.41	$42K	30,000	Form 4

Wang Ronghua

Chairman, CEO · Director

Purchase

Date

Jun 16

13,800

Price

$1.10

Value

$15K

View Form 4 on SEC.gov

Wang Ronghua

Chairman, CEO · Director

Purchase

Date

Jun 15

14,350

Price

$1.19

Value

$17K

View Form 4 on SEC.gov

Wang Ronghua

Chairman, CEO · Director

Purchase

Date

Jun 14

35,100

Price

$1.23

Value

$43K

View Form 4 on SEC.gov

Wang Ronghua

Chairman, CEO · Director

Purchase

Date

Jun 13

22,050

Price

$1.24

Value

$27K

View Form 4 on SEC.gov

Wang Ronghua

Chairman, CEO · Director

Purchase

Date

Jun 10

19,700

Price

$1.21

Value

$24K

View Form 4 on SEC.gov

Wang Ronghua

Chairman, CEO · Director

Purchase

Date

Jun 9

12,000

Price

$1.22

Value

$15K

View Form 4 on SEC.gov

Wang Ronghua

Chairman, CEO · Director

Purchase

Date

Jun 8

34,600

Price

$1.26

Value

$44K

View Form 4 on SEC.gov

Wang Ronghua

Chairman, CEO · Director

Purchase

Date

Jun 7

8,600

Price

$1.25

Value

$11K

View Form 4 on SEC.gov

Wang Ronghua

Chairman, CEO · Director

Purchase

Date

Jun 6

10,300

Price

$1.24

Value

$13K

View Form 4 on SEC.gov

Wang Ronghua

Chairman, CEO · Director

Purchase

Date

Jun 3

6,900

Price

$1.27

Value

$9K

View Form 4 on SEC.gov

Wang Ronghua

Chairman, CEO · Director

Purchase

Date

Jun 2

12,200

Price

$1.29

Value

$16K

View Form 4 on SEC.gov

Wang Ronghua

Chairman, CEO · Director

Purchase

Date

Jun 1

100

Price

$1.38

Value

$138

View Form 4 on SEC.gov

Wang Ronghua

Chairman, CEO · Director

Purchase

Date

Jun 1

200

Price

$1.37

Value

$274

View Form 4 on SEC.gov

Wang Ronghua

Chairman, CEO · Director

Purchase

Date

Jun 1

1,300

Price

$1.36

Value

$2K

View Form 4 on SEC.gov

Wang Ronghua

Chairman, CEO · Director

Purchase

Date

Jun 1

1,700

Price

$1.35

Value

$2K

View Form 4 on SEC.gov

Wang Ronghua

Chairman, CEO · Director

Purchase

Date

Jun 1

1,700

Price

$1.33

Value

$2K

View Form 4 on SEC.gov

Wang Ronghua

Chairman, CEO · Director

Purchase

Date

Jun 1

2,500

Price

$1.32

Value

$3K

View Form 4 on SEC.gov

Wang Ronghua

Chairman, CEO · Director

Purchase

Date

Jun 1

1,811

Price

$1.31

Value

$2K

View Form 4 on SEC.gov

Wang Ronghua

Chairman, CEO · Director

Purchase

Date

Jun 1

1.089

Price

$1.30

Value

View Form 4 on SEC.gov

Pan Zibing

CFO

Purchase

Date

May 19

30,000

Price

$1.41

Value

$42K

View Form 4 on SEC.gov

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About BSPM insider trading

BSPM insider trades

Biostar Pharmaceuticals, Inc. (BSPM) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including BSPM. Over the past 12 months, 0 insiders have filed transactions with the SEC. BSPM insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Biostar Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

BSPM insider trading · 5 questions

The insiders of Biostar Pharmaceuticals, Inc. (BSPM) include executives and directors such as BSPM, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

BSPM board member insider tradingwho are BSPM insidersBSPM insider rosterBiostar Pharmaceuticals, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026